FDA Inspection
N-Molecular Inc. d.b.a. SOFIEN-Molecular Inc. d.b.a. SOFIE – FDA Inspection, May 16, 2019
Record Details
This FDA Inspection record concerns N-Molecular Inc. d.b.a. SOFIE, with an inspection on May 16, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 69afb2fb-a950-4464-b884-363221e614ef
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1089718
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 212.60(e)Equipment
- 21 CFR 212.20(e)Written QA procedures established, followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of N-Molecular Inc. d.b.a. SOFIE
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2024 | VAI | New England District Office | Drug Quality Assurance |
| February 28, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 11, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for N-Molecular Inc. d.b.a. SOFIE
- FDA Inspection 1250020 - 2024-11-20
- FDA Inspection 1042553 - 2018-02-28
- FDA Inspection 939620 - 2015-08-07
- FDA Inspection 859853 - 2013-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.